Heparin - A Century of Progress

Heparins remain amongst the most commonly used drugs in clinical practice.  Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume i...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Lever, Rebecca (Επιμελητής έκδοσης), Mulloy, Barbara (Επιμελητής έκδοσης), Page, Clive P. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2012.
Σειρά:Handbook of Experimental Pharmacology, 207
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03059nam a22005535i 4500
001 978-3-642-23056-1
003 DE-He213
005 20151103123926.0
007 cr nn 008mamaa
008 120507s2012 gw | s |||| 0|eng d
020 |a 9783642230561  |9 978-3-642-23056-1 
024 7 |a 10.1007/978-3-642-23056-1  |2 doi 
040 |d GrThAP 
050 4 |a RM1-950 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
082 0 4 |a 615  |2 23 
245 1 0 |a Heparin - A Century of Progress  |h [electronic resource] /  |c edited by Rebecca Lever, Barbara Mulloy, Clive P. Page. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2012. 
300 |a XIV, 462 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Handbook of Experimental Pharmacology,  |x 0171-2004 ;  |v 207 
505 0 |a Part 1. Introduction -- Part 2. Unfractionated and Low Molecular Weight Heparins -- Part 3. Clinical Use of Heparin and LMWH -- Part 4. Non Anticoagulant Indictions for Heparin and Related Compounds -- Part 5. Heparin-like Entities. 
520 |a Heparins remain amongst the most commonly used drugs in clinical practice.  Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume is to summarise the developments that have led to the current status of both heparins as drugs and the field of heparin research, with a focus on the particularly rapid progress that has been made over the past three decades. Individual sections are dedicated to the nature of heparin as a biological molecule, the current approaches and techniques that are used to ensure the safety and reliability of heparin as a medicine, the clinical pharmacology of heparin as an anticoagulant drug, effects and potential applications of heparin aside of those involving haemostasis and, finally, the nature and potential uses of heparin-like materials from both natural and synthetic sources. 
650 0 |a Medicine. 
650 0 |a Molecular biology. 
650 0 |a Pharmacology. 
650 0 |a Pharmaceutical technology. 
650 0 |a Internal medicine. 
650 0 |a Hematology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Pharmaceutical Sciences/Technology. 
650 2 4 |a Internal Medicine. 
650 2 4 |a Hematology. 
700 1 |a Lever, Rebecca.  |e editor. 
700 1 |a Mulloy, Barbara.  |e editor. 
700 1 |a Page, Clive P.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642230554 
830 0 |a Handbook of Experimental Pharmacology,  |x 0171-2004 ;  |v 207 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-23056-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)